GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 789 filers reported holding GLAXOSMITHKLINE PLC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $841,000 | -32.0% | 22,200 | -15.6% | 0.05% | +8.3% |
| Q4 2019 | $1,236,000 | -22.8% | 26,300 | -29.9% | 0.05% | -33.3% |
| Q3 2019 | $1,601,000 | +108.5% | 37,500 | +95.3% | 0.07% | +140.0% |
| Q2 2019 | $768,000 | -10.4% | 19,200 | -6.3% | 0.03% | +3.4% |
| Q1 2019 | $857,000 | +9.5% | 20,500 | 0.0% | 0.03% | +20.8% |
| Q4 2018 | $783,000 | -4.9% | 20,500 | 0.0% | 0.02% | +20.0% |
| Q3 2018 | $823,000 | – | 20,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |